logo

Pfizer Inc. (PFE)



Trade PFE now with
  Date
  Headline
2/15/2018 8:34:58 AM Merck KGaA And Pfizer Provide Update On Phase III JAVELIN Lung 200 Trial Of Avelumab Monotherapy
2/14/2018 8:34:17 AM Pfizer Receives Breakthrough Therapy Designation From FDA For PF-04965842 For Moderate-to-Severe Atopic Dermatitis
2/12/2018 8:10:01 AM US,EU,Japan Authorities Accept Regulatory Submissions For Review Of Pfizer 3rd-Generation ALK Inhibitor Lorlatinib
2/6/2018 5:10:50 AM NetVation DL Medicine Enters Two-year Research Collaboration With Pfizer
2/5/2018 5:13:13 PM Astellas Pharma And Pfizer Announce Results From Phase 3 PROSPER Trial In Patients With M0 CRPC
1/30/2018 6:49:24 AM Pfizer Inc. Earnings Climb In Q4
1/30/2018 6:46:22 AM Pfizer Q4 Adjusted EPS $0.62 Vs $0.47 Last Year; Analysts Estimated $0.56
1/24/2018 8:32:14 AM Pfizer Says REFLECTIONS B3281006, Safety And Efficacy Study Of PF-05280586 Versus MabThera, Met Primary Endpoint
1/18/2018 8:31:13 AM Kite Enters Clinical Trial Collaboration With Pfizer